Acute Postinfectious Glomerulonephritis in Children

  • Bernardo Rodríguez-Iturbe
  • Behzad Najafian
  • Alfonso Silva
  • Charles E. Alpers
Living reference work entry


Postinfectious glomerulonephritis (PIGN) comprises a large group of glomerulonephridities that are caused by infectious agents. Acute glomerulonephritis is a term that defines a pathological lesion that may be asymptomatic or it may be manifested clinically with the acute nephritic syndrome, or the nephrotic syndrome, or with a rapidly progressive renal failure. In this chapter we will deal with the most common glomerulonephridities that result from bacterial infections: poststreptococcal glomerulonephritis, IgA-dominant glomerulonephritis associated with staphylococcal infections, and glomerulonephritis associated with bacterial endocarditis, infected atrial ventricular shunts, syphilis, and deep-seated infections. Since poststreptococcal glomerulonephritis is the best known of the acute postinfectious glomerulonephritis and its most frequent clinical picture is the acute nephritic syndrome, the terms poststreptococcal glomerulonephritis, acute glomerulonephritis, and acute nephritic syndrome are often, and incorrectly, used interchangeably. The incidence of PIGN is declining in affluent societies where most cases now occur in elderly individuals, many with comorbid debilitating conditions such as alcoholism, HIV infection, drug abuse, and diabetes. Nevertheless, PIGN, and specifically poststreptococcal glomerulonephritis, is still frequent in children in poor communities with limited access to medical care.


Lupus Nephritis Infective Endocarditis Glomerular Basement Membrane Staphylococcal Infection Crescentic Glomerulonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Germuth FG. Comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type. J Exp Med. 1953;97:257–82.PubMedCentralPubMedGoogle Scholar
  2. 2.
    Dixon FJ, Feldman JD, Vasquez JJ. Experimental glomerulonephritis: the pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961;113:899–920.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Germuth FG, Senterfit LB, Dressman GR. Immune complex disease. V. The nature of circulating complexes associated with glomerular alterations in chronic BSA-rabbit system. Johns Hopkins Med J. 1972;130:344–57.PubMedGoogle Scholar
  4. 4.
    Vogt A, Schmiedeke T, Stockl FW, Sugisaki Y, Mertz A, Batsford S. The role of cationic proteins in the pathogenesis of immune complex glomerulonephritis. Nephrol Dial Transplant. 1990;5 Suppl 1:6–9.PubMedGoogle Scholar
  5. 5.
    Becker CG, Murphy GE. The experimental induction of glomerulonephritis like that in man by infection with Group A streptococci. J Exp Med. 1968;127:1–23.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Zegers RH, Weigl A, Steptoe A. The death of Wolfgang Amadeus Mozart: an epidemiologic perspective. Ann Intern Med. 2009;151:274–8.PubMedGoogle Scholar
  7. 7.
    Dochez AR, Sherman L. The significance of Streptococcus hemolyticus in scarlet fever and the preparation of a specific antiscarlatinal serum by immunization of the horse to Streptococcus hemolyticus. J Am Med Assoc. 1924;82:542–4.Google Scholar
  8. 8.
    Futcher PH. Glomerular nephritis following skin infections. Arch Intern Med. 1940;65:1192–210.Google Scholar
  9. 9.
    von Ergebn PC. Inn Med Kinderheilk. 1910;5:459–539 translated into English in: von Pirquet C. Allergy. Arch Int Med. 1911;7:259–88, 382–436.Google Scholar
  10. 10.
    Rodriguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007;71:1094–104.PubMedGoogle Scholar
  11. 11.
    Montseny JJ, Meyrier A, Kleinknecht D, Callard P. The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore). 1995;74:63–73.Google Scholar
  12. 12.
    Thongboonkerd V, Luengpailin J, Cao J, Pierce WM, Cai J, Klein JB, Doyle RJ. Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem. 2002;277:16599–605.PubMedGoogle Scholar
  13. 13.
    Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. 2008;23:1101–16.PubMedGoogle Scholar
  14. 14.
    Becquet O, Pasche J, Gatti H, Chenel C, Abély M, Morville P, Pietrement C. Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol. 2010;25:275–80.PubMedGoogle Scholar
  15. 15.
    Rodriguez-Iturbe B, Mezzano S. Infections and kidney diseases: a continuing global challenge. In: El Nahas M, editor. Kidney diseases in the developing world and ethnic minorities. London: M. Taylor & Francis; 2005. p. 59–82.Google Scholar
  16. 16.
    Currie BJ, Brewster DR. Childhood infections in the tropical north of Australia. J Paed Child Health. 2001;37:326–30.Google Scholar
  17. 17.
    Marshall CS, Cheng AC, Markey PG, Towers RJ, Richardson LJ, Fagan PK, Scott L, Krause VL, Currie BJ. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg. 2011;85(4):703–10.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Carapetis JR, Steer AC, Mullholand EK, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet. 2005;5:685–94.PubMedGoogle Scholar
  19. 19.
    Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19:1855–64.PubMedGoogle Scholar
  20. 20.
    Bach JF, Chalons S, Forier E, Elana G, Jouannelle J, Kayemba S, Delbois D, Mosser A, Saint-Aime C, Berchel C. 10-year educational programme aimed at rheumatic fever in two French Caribbean Islands. Lancet. 1966;347:644–8.Google Scholar
  21. 21.
    Anthony BF, Kaplan EL, Wannamaker LW, Briese FW, Chapman SS. Attack rates of acute nephritis after type 49 streptococcal infections of the skin and of the respiratory tract. J Clin Invest. 1969;48:1697–704.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Poon-King T, Mohammed I, Cox R, Potter EV, Simon NM, Siegel AC, Earle DP. Recurrent epidemic nephritis in South Trinidad. N Engl J Med. 1967;277:728–33.PubMedGoogle Scholar
  23. 23.
    Rodriguez-Iturbe B. Epidemic poststreptococcal glomerulonephritis. Kidney Int. 1984;25:129–36.PubMedGoogle Scholar
  24. 24.
    Balter S, Benin A, Pinto SW, Teixeira LM, Alvim GG, Luna E, Jackson D, LaClaire L, Elliott J, Facklam R, Schuchat A. Epidemic nephritis in Nova Serrana, Brazil. Lancet. 2000;355:1776–80.PubMedGoogle Scholar
  25. 25.
    Nicholson ML, Ferdinand L, Sampson JS, Benin A, Balter S, Pinto SW, Dowell SF, Facklam RR, Carlone GM, Beall B. Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein to confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-liked proteins from isolates obtained from different host species. J Clin Microbiol. 2000;38:4126–30.PubMedCentralPubMedGoogle Scholar
  26. 26.
    Rammelkamp CH, Weaver RS, Dingle JH. Significance of the epidemiologic differences between acute nephritis and acute rheumatic fever. Trans Assoc Am Phys. 1952;65:168–75.PubMedGoogle Scholar
  27. 27.
    Segal D, Earle DP. A consideration of certain biological differences between glomerulonephritis and rheumatic fever. Am J Med Sci. 1941;201:528–39.Google Scholar
  28. 28.
    Francis AJ, Nimmo GR, Efstratiou A, Galanis V, Nuttall N. Investigation of milk- borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia. J Infect. 1993;27:317–23.PubMedGoogle Scholar
  29. 29.
    Oda T, Yoshizawa N, Yamakami K, Tamura K, Kuroki A, Sugisaki T, Sawanobori E, Higashida K, Ohtomo Y, Hotta O, Kumagai H, Miura S. Localization of nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Hum Pathol. 2010;41(9):1276–85.PubMedGoogle Scholar
  30. 30.
    Yoshizawa N, Yamakami K, Fujino M, Oda T, Tamura K, Matsumoto K, Sugisaki T, Boyle MD. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. 2004;15:1785–93.PubMedGoogle Scholar
  31. 31.
    Poon-King T, Bannan J, Viteri A, Cu G, Zabriskie JB. Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med. 1993;178:759–63.PubMedGoogle Scholar
  32. 32.
    Vogt A, Batsford S, Rodríguez-Iturbe B, García R. Cationic antigens in poststreptococcal glomerulonephritis. Clin Nephrol. 1983;20:271–9.PubMedGoogle Scholar
  33. 33.
    Parra G, Rodríguez-Iturbe B, Batsford S, Vogt A, Mezzano S, Olavarría F, Exeni R, Laso M, Orta N. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. 1998;54:509–17.PubMedGoogle Scholar
  34. 34.
    Batsford SR, Mezzano S, Mihatsch M, Schiltz E, Rodríguez-Iturbe B. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int. 2005;68:1120–9.PubMedGoogle Scholar
  35. 35.
    Oda T, Tamura K, Yoshizawa N, Sugisaki T, Matsumoto K, Hattori M, Sawai T, Namikoshi T, Yamada M, Kikuchi Y, Suzuki S, Miura S. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant. 2008;23:2254–9.PubMedGoogle Scholar
  36. 36.
    Zhang L, Ignatowski TA, Spengler RN, Noble B, Stinson MW. Streptococcal histone induces murine macrophages to produce interleukin-1 and tumor necrosis factor alpha. Infect Immun. 1999;67:6473–7.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Romero M, Mosquera J, Novo E, Fernandez L, Parra G. Erythrogenic toxin type B and its precursor isolated from streptococci induce leukocyte infiltration in normal rat kidneys. Nephrol Dial Transplant. 1999;14:1867–74.PubMedGoogle Scholar
  38. 38.
    Viera N, Pedreanez A, Rincon J, Mosquera J. Streptococcal zymogen type B induces angiotensin II in mesangial cells and leukocytes. Pediatr Nephrol. 2009;24:1005–11.PubMedGoogle Scholar
  39. 39.
    Tsao N, Cheng MH, Yang HC, Wang YC, Liu YL, Kuo CF. Determining antibody- binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection. PLoS One. 2013;8(1):e55028.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Beres SB, Sesso R, Pinto SW, Hoe NP, Porcella SF, Deleo FR, Musser JM. Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One. 2008;3:e3026. doi:10.1371/.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Perez-Caballero D, Garcia-Laorden I, Cortes G, Wessels MR, de Córdoba SR, Albertí S. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involve two different cell surface molecules. J Immunol. 2004;173:6899–904.PubMedGoogle Scholar
  42. 42.
    Them A, Stenberg L, Dahback B, Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4bP), a regulatory component of the complement system. J Immunol. 1995;154:375–86.Google Scholar
  43. 43.
    Frémeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine MD. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with a C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant. 1994;9:1747–50.PubMedGoogle Scholar
  44. 44.
    Berge A, Kihlberg BM, Sjöholm AG, Björck L. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem. 1997;272:20774–81.PubMedGoogle Scholar
  45. 45.
    Oshawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T. Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int. 1999;56:1158–9.Google Scholar
  46. 46.
    Skattum L, Akesson P, Truedsson L, Sjöholm AG. Antibodies against four proteins from a Streptococcus pyogenes serotype M1 strain and levels of circulating mannan-binding lectin in acute poststreptococcal glomerulonephritis. Int Arch Allergy Immunol. 2006;140:9–19.PubMedGoogle Scholar
  47. 47.
    Parra G, Platt JL, Falk RJ, Rodriguez-Iturbe B, Michael AF. Cell populations and membrane attack complex in glomeruli and patients with poststreptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. Clin Exp Immunol Immunopathol. 1984;33:324–32.Google Scholar
  48. 48.
    Parra G, Romero M, Henríquez-LaRoche C, Rodriguez-Iturbe B. Expression of adhesion molecules in poststreptococcal glomerulonephritis. Nephrol Dial Transplant. 1994;9:1412–4.PubMedGoogle Scholar
  49. 49.
    Pedreanez A, Viera N, Rincon J. Increased IL-6 in supernatant of rat mesangial cell cultures treated with erythrogenic toxin type B and its precursor isolated from nephritogenic streptococci. Am J Nephrol. 2006;26:75–81.PubMedGoogle Scholar
  50. 50.
    Mezzano S, Burgos ME, Olavarría F, Caorsi I. Immunohistochemical localization of IL-8 and TGF-beta in streptococcal glomerulonephritis. J Am Soc Nephrol. 1997;8:234–41.PubMedGoogle Scholar
  51. 51.
    Asami T, Tanaka A, Gunji T, Sakai K. Elevated serum and urine sialic acid levels in renal diseases of childhood. Clin Nephrol. 1985;23:112–9.PubMedGoogle Scholar
  52. 52.
    Rodriguez-Iturbe B, Katiyar VN, Coello J. Neuraminidase activity and free sialic acid levels in the serum of patients with acute poststreptococcal glomerulonephritis. N Engl J Med. 1981;304:1506–10.PubMedGoogle Scholar
  53. 53.
    Marín C, Mosquera J, Rodríguez-Iturbe B. Neuraminidase promotes neutrophil, lymphocyte and macrophage infiltration in the normal rat kidney. Kidney Int. 1995;47:88–95.PubMedGoogle Scholar
  54. 54.
    Duvic C, Desramé J, Hérody M, Nédélec G. Acute poststreptococcal glomerulonephritis associated with thrombotic microangiopathy in an adult. Clin Nephrol. 2000;54:169–73.PubMedGoogle Scholar
  55. 55.
    Burova LA, Nagornev VA, Pigarevsky PV, Gladilina MM, Seliverstova VG, Schalen C, Totolian AA. Triggering of renal tissue damage in the rabbit by IgG Fc receptor-positive group A streptococci. Acta Pathol Microb Immun Scand. 1998;106:277–87.Google Scholar
  56. 56.
    Ardiles LG, Valderrama G, Moya P, Mezzano SA. Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis. Clin Nephrol. 1997;47:1–5.PubMedGoogle Scholar
  57. 57.
    Rodriguez-Iturbe B, Rubio L, Garcia R. Attack rate of poststreptococcal glomerulonephritis in families. A prospective study. Lancet. 1981;1:401–3.PubMedGoogle Scholar
  58. 58.
    Prasto J, Kaplan BS, Russo P, Chan E, Smith RJ, Meyers KE. Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy). Eur J Pediatr. 2014;173:767–72.PubMedGoogle Scholar
  59. 59.
    Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC. Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis. 2012;60(1):121–5.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Dodge WF, Spargo BF, Travis LB. Occurrence of acute glomerulonephritis in sibling contacts of children with sporadic acute glomerulonephritis. Pediatrics. 1967;40:1028–30.PubMedGoogle Scholar
  61. 61.
    Juncos LI. Intrarenal mechanisms of salt and water retention in the nephritic syndrome. Kidney Int. 2002;61:1182–95.PubMedGoogle Scholar
  62. 62.
    Kim SW, Frøkiaer J, Nielsen S. Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel. Nephrology. 2007;12 Suppl 3:S8–10.PubMedGoogle Scholar
  63. 63.
    Rodríguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int. 2002;62:1379–84.PubMedGoogle Scholar
  64. 64.
    Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT. C3 glomerulopathy: consensus report. Kidney Int. 2013;84:1079–89.Google Scholar
  65. 65.
    Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D’Agati VD. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore). 2008;87:21–32.Google Scholar
  66. 66.
    Nasr SH, D’Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011;119:18–25.Google Scholar
  67. 67.
    Sorger K, Gessler M, Hubner FK, Kohler H, Olbing H, Schulz W, Thoenes GH, Thoenes W. Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol. 1987;27:111–24.PubMedGoogle Scholar
  68. 68.
    Edelstein CL, Bates WD. Subtypes of acute postinfectious glomerulonephritis: a clinico-pathological correlation. Clin Nephrol. 1992;38:311–7.PubMedGoogle Scholar
  69. 69.
    Oite T, Batsford SR, Mihatsch MJ, Takamiya H, Vogt A. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J Exp Med. 1982;55(2):460–7.Google Scholar
  70. 70.
    Haas M. Incidental healed postinfectious glomerulonephritis: a study of 1012 renal biopsy specimens examined by electron microscopy. Human Pathol. 2003;34:3–10.Google Scholar
  71. 71.
    Cebul DR, Poses RM. The comparative cost-effectiveness of statistical decision rules and experienced physicians in pharyngitis management. J Am Med Assoc. 1986;256:3353–7.Google Scholar
  72. 72.
    McIsaac WJ, White D, Tannenbaum D. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Can Med Assoc J. 1998;158:75–83.Google Scholar
  73. 73.
    American Academy of Pediatrics, Committee on Infectious Diseases. Group A streptococcal infections. In: The red book. Elk Grove Village: American Academy of Pediatrics; 2000. p. 526–92.Google Scholar
  74. 74.
    Webb KH, Needham CA, Kurtz SR. Use of a high-sensitivity rapid strep test without culture confirmation of negative results: 2 years’ experience. J Fam Pract. 2000;49:34–6.PubMedGoogle Scholar
  75. 75.
    Fine AM, Nizet V, Mandl KD. Participatory medicine: a home score for streptococcal pharyngitis enabled real-time biosurveillance. Ann Intern Med. 2013;159:577–83.PubMedCentralPubMedGoogle Scholar
  76. 76.
    Zoch-Zwierz W, Wasilewska A, Biernacka A, Tomaszewska B, Winiecka W, Wierciński R, Porowski T. The course of post-streptococcal glomerulonephritis depending on methods of treatment of the preceding respiratory tract infection. Wiad Lek. 2001;54:56–63.PubMedGoogle Scholar
  77. 77.
    Billal DS, Hotomi M, Yamauchi K, Fujihara K, Tamura S, Kuki K, Sugita R, Endou M, Mukaigawa J, Yamanaka N. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction. J Infect Chem. 2004;10:115–20.Google Scholar
  78. 78.
    Tamayo J, Pérez-Trallero E, Gómez-Garcés JL, Alós JI. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Chemother. 2005;56:780–2.PubMedGoogle Scholar
  79. 79.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV. Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis. 2005;41:599–608.PubMedGoogle Scholar
  80. 80.
    Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV. Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother. 2008;61:603–11.PubMedGoogle Scholar
  81. 81.
    Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P. Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. Pediatr Infect Dis J. 1999;18:327–32.PubMedGoogle Scholar
  82. 82.
    Powell HR, McCredie D, Rotenberg F. Response to frusemide in acute renal failure. Dissociation of renin and diuretic responses. Clin Nephrol. 1980;14:55–9.PubMedGoogle Scholar
  83. 83.
    Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. 2008;20:157–62.PubMedGoogle Scholar
  84. 84.
    Potter EV, Lipschultz SA, Abidh S, Poon-King T, Earle DP. Twelve to seventeen- year follow up of patients with acute poststreptococcal glomerulonephritis in Trinidad. N Engl J Med. 1982;307:725–9.PubMedGoogle Scholar
  85. 85.
    Baldwin DS, Gluck MC, Schacht RG, Gallo G. The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med. 1974;80:342–58.PubMedGoogle Scholar
  86. 86.
    Sesso R, Pinto SWL. Five-year follow-up of patients with epidemic glomerulonephritis due to Streptococcus zooepidemicus. Nephrol Dial Transplant. 2005;20:1808–13.PubMedGoogle Scholar
  87. 87.
    Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, Kile E, Walker KA, Wang Z. The multidimensional nature of renal disease: rates and association of albuminuria in an Australian Aboriginal community. Kidney Int. 1998;54:1296–304.PubMedGoogle Scholar
  88. 88.
    Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, Swanson CE, Mathews JD, McCredie DA. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int. 2012;81:1026–32.PubMedGoogle Scholar
  89. 89.
    Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, Irie F, Goto M, Igarashi M, Iitsuka T. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.PubMedGoogle Scholar
  90. 90.
    Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L, Nadasdy T. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol. 2006;1:1179–86.PubMedGoogle Scholar
  91. 91.
    Usui J, Kobayashi M, Ebihara I, Koyama A, Yamagata K. Methicillin-resistant Staphylococcus aureus associated glomerulonephritis on the decline: decreased incidence since the 1990s. Clin Exp Nephrol. 2011;15:184–6.PubMedGoogle Scholar
  92. 92.
    Worawichawong S, Girard L, Trpkov K, Gough JC, Gregson DB, Benediktsson H. Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection. Hum Pathol. 2011;42:279–84.PubMedGoogle Scholar
  93. 93.
    Wen YK, Chen ML. IgA-dominant postinfectious glomerulonephritis: not peculiar to staphylococcal infection and diabetic patients. Ren Fail. 2011;33:480–5.PubMedGoogle Scholar
  94. 94.
    Kimata T, Tsuji S, Yoshimura K, Tsukaguchi H, Kaneko K. Methicillin- resistant Staphylococcus aureus elated glomerulonephritis in a child. Pediatr Nephrol. 2012;11:2149–52.Google Scholar
  95. 95.
    Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Human Pathol. 2008;39:1309–16.Google Scholar
  96. 96.
    Yoh K, Kobayashi M, Yamaguchi N, Hirayama K, Ishizu T, Kikuchi S, Iwabuchi S, Muro K, Nagase S, Aoyagi K, Kondoh M, Takemura K, Yamagata K, Koyama A. Cytokines and T-cell responses in superantigen- related glomerulonephritis following methicillin-resistant Staphylococcus aureus infection. Nephrol Dial Transplant. 2000;8:1170–4.Google Scholar
  97. 97.
    Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, Nagata M, Yoh K, Yamagata K, Muro K, Kobayashi M, Ohtani K, Shimizu T, Shimizu T. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004;66:121–32.PubMedGoogle Scholar
  98. 98.
    Sharmin S, Shimizu Y, Hagiwara M, Hirayama K, Koyama A. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol. 2004;17:504–11.PubMedGoogle Scholar
  99. 99.
    Nasr SH, Markowitz GS, Whelan JD, Albanese JJ, Rosen RM, Fein DA, Kim SS, D’Agati VD. IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol. 2003;34:1235–41.PubMedGoogle Scholar
  100. 100.
    Satoskar AA, Molenda M, Scipio P, Shim R, Zirwas M, Variath RS, Brodsky SV, Nadasdy GM, Hebert L, Rovin B, Nadasdy T. Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection – associated glomerulonephritis – a diagnostic pitfall. Clin Nephrol. 2013;7(9):302–12.Google Scholar
  101. 101.
    Okuyama S, Wakui H, Maki N, Kuroki J, Nishinari T, Asakura K, Komatsuda A, Sawada K. Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clin Nephrol. 2008;70:344–7.PubMedGoogle Scholar
  102. 102.
    Neugarten J, Baldwin DS. Glomerulonephritis in bacterial endocarditis. Am J Med. 1984;77:297–304.PubMedGoogle Scholar
  103. 103.
    Khalighi MA, Nguyen S, Wiedeman JA, Palma-Diaz MF. Bartonella endocarditis- associated glomerulonephritis: a case report and review of the literature. Am J Kidney Dis. 2014;63:1060–5.PubMedGoogle Scholar
  104. 104.
    Löhlein M. Über hämorrhagische Nierenalffek bei chronischer ulzeröser Endokarditis embolische nichteiterige Herdnephritis. Med Klin. 1910;6:375–9.Google Scholar
  105. 105.
    Eknoyan G. Renal complications of bacterial endocarditis. Am J Nephrol. 1985;5:457–69.PubMedGoogle Scholar
  106. 106.
    Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, Littler WA. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000;15:1782–7.PubMedGoogle Scholar
  107. 107.
    Paterick TE, Paterick TJ, Nishimura RA, Nishimura RA, Steckelberg JM. Complexity and subtlety of infective endocarditis. Mayo Clin Proc. 2007;82:615–21.PubMedGoogle Scholar
  108. 108.
    Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One. 2013;8:e60033.PubMedCentralPubMedGoogle Scholar
  109. 109.
    Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132:1025–35.PubMedGoogle Scholar
  110. 110.
    Tlevjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, Moustafa SE, Hoskin TL, Mandrekar JN, Wilson WR, Baddour LM. Temporal trends in infective endocarditis: a population- based study in Olmsted County, Minnesota. J Am Med Assoc. 2005;293:3022–8.Google Scholar
  111. 111.
    David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microb Rev. 2010;23:616–87.Google Scholar
  112. 112.
    David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles? PLoS One. 2011;6(4):e18217.PubMedCentralPubMedGoogle Scholar
  113. 113.
    Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant. 2004;19:1360–2.PubMedGoogle Scholar
  114. 114.
    Rekik S, Trabelsi I, Hentati M, Hammami A, Jemaa MB, Hachicha J, Kammoun S. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis. Clin Exp Nephrol. 2009;13:350–4.PubMedGoogle Scholar
  115. 115.
    Johnson JA, Boyce TG, Cetta F, Steckelberg JM, Johnson JN. Infective endocarditis in the pediatric patient: a 60-year single-institution review. Mayo Clin Proc. 2012;87:629–35.PubMedCentralPubMedGoogle Scholar
  116. 116.
    Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM. Induction of experimental endocarditis by continuous low- grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun. 2011;79:2006–11.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN. Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study. BMC Infect Dis. 2011;11:298.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Que YA, Moreillon P. Infective endocarditis. Nature Rev Cardiol. 2011;8:322–36.Google Scholar
  119. 119.
    Mylonakis E, Calderwood SB. Infective endocarditis in adults. New Eng J Med. 2001;345:1318–30.PubMedGoogle Scholar
  120. 120.
    Yum M, Wheat LJ, Maxwell D, Edwards JL. Immunofluorescent localization of Staphylococcus aureus antigen in acute bacterial endocarditis nephritis. Am J Clin Pathol. 1978;70:832–5.PubMedGoogle Scholar
  121. 121.
    Salgado-Pabón W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR, Peterson ML, Schlievert PM. Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. MBio. 2013;4(4):pii: e00494-13. doi:10.1128.Google Scholar
  122. 122.
    McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008–14.PubMedGoogle Scholar
  123. 123.
    Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21:2184–90.PubMedGoogle Scholar
  124. 124.
    Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O’Donnell P, Chambers J, Austen C, Goldsmith DJ. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64:720–7.PubMedGoogle Scholar
  125. 125.
    Fernández-Guerrero ML, Álvarez B, Manzarbeitia F, Renedo G. Infective endocarditis at autopsy: a review of pathologic manifestations and clinical. Medicine (Baltimore). 2012;91:152–64.Google Scholar
  126. 126.
    Yoshinaga M, Niwa K, Niwa A, Ishiwada N, Takahashi H, Echigo S, Nakazawa M. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol. 2008;101:114–8.PubMedGoogle Scholar
  127. 127.
    Venkatesan C, Wainwright MS. Pediatric endocarditis and stroke: a single-center retrospective review of seven cases. Pediatr Neurol. 2008;38:243–7.PubMedCentralPubMedGoogle Scholar
  128. 128.
    Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol. 1998;49:96–101.PubMedGoogle Scholar
  129. 129.
    Koeda C, Tashiro A, Itoh T, Okabayashi H, Nakamura M. Mild renal dysfunction on admission is an important prognostic predictor in patients with infective endocarditis: a retrospective single-center study. Intern Med. 2013;52:1013–8.PubMedGoogle Scholar
  130. 130.
    Agarwal A, Clemens J, Sedmark DD, Imler D, Nahman Jr NS, Orsinelli DA, Hebert LA. Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol. 1997;8:1971–6.PubMedGoogle Scholar
  131. 131.
    Fukuda M, Motokawa M, Usami T, Oikawa T, Morozumi K, Yoshida A, Kimura G. PR3-ANCA-positive crescentic necrotizing glomerulonephritis accompanied by isolated pulmonic valve infective endocarditis, with reference to previous reports of renal pathology. Clin Nephrol. 2006;66:202–9.PubMedGoogle Scholar
  132. 132.
    Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum. 2000;43:226–31.PubMedGoogle Scholar
  133. 133.
    Peng H, Chen WF, Wu C, Chen YR, Peng B, Paudel SD, Lou TQ. Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangiitis (Wegener’s granulomatosis) involving both the kidney and lung. BMC Nephrol. 2012;13:174.PubMedCentralPubMedGoogle Scholar
  134. 134.
    Baehr G. Glomerular lesions of subacute bacterial endocarditis. J Exp Med. 1912;15:330–47.PubMedCentralPubMedGoogle Scholar
  135. 135.
    Boulton-Jones JM, Sissons JGP, Evans DJ, Peters DK. Renal lesions of subacute infective endocarditis. British Med J. 1974;2:11–4.Google Scholar
  136. 136.
    Morel-Maroger L, Sraer JD, Herreman G, Godeau P. Kidney in subacute endocarditis. Pathological and immunofluorescence findings. Arch Pathol. 1972;94:205–13.PubMedGoogle Scholar
  137. 137.
    Fitzgibbons LN, Puls DL, Mackay K, Forrest GN. Management of gram-positive coccal bacteremia and hemodialysis. Am J Kidney Dis. 2011;57:624–40.PubMedGoogle Scholar
  138. 138.
    Badour LM, Wilson WR, Bayer AS, Fowler Jr VG, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis. Diagnosis, antimicrobial therapy and management of complications. Circulation. 2005;111:3167–84.Google Scholar
  139. 139.
    Konstantinov KN, Harris AA, Hartshorne MF, Tzamaloukas AH. Symptomatic anti-neutrophil cytoplasmic antibody-positive disease complicating subacute bacterial endocarditis: to treat or not to treat? Case Rep Nephrol Urol. 2012;2:25–32.PubMedCentralPubMedGoogle Scholar
  140. 140.
    Haffner D, Schinderas F, Aschoff A. The clinical spectrum of shunt nephritis. Nephrol Dial Transplant. 1997;12:1143–8.PubMedGoogle Scholar
  141. 141.
    Kubota M, Sakata Y, Saeki N, Yamaura A, Ogawa M. A case of shunt nephritis diagnosed 17 years after ventriculoatrial shunt implantation. Clin Neurol Neurosurg. 2001;103:245–6.PubMedGoogle Scholar
  142. 142.
    Korinek AM, Fulla-Oller L, Boch AL, Golmard JL, Hadiji B, Puybasset L. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults an 8- year study. J Neurosurg Sci. 2011;55:161–3.Google Scholar
  143. 143.
    Dobrin RS, Day NK, Quie PG, Moore HL, Vernier HL, Michael AF, Fish AJ. The role of complement, immunoglobulin and bacterial antigens in coagulase-negative Staphylococcus shunt nephritis. Am J Med. 1975;59:660–73.PubMedGoogle Scholar
  144. 144.
    Groeneveld AB, Nommensen FE, Mullink H, Ooms EC, Bode WA. Shunt nephritis associated with Propionibacterium acnes with demonstration of the antigen in the glomeruli. Nephron. 1982;32:365–9.PubMedGoogle Scholar
  145. 145.
    Nagashima T, Hirata D, Yamamoto H, Okazaki H, Minota S. Antineutrophil cytoplasmic autoantibody specific for proteinase 3 in a patient with shunt nephritis induced by Gemella morbillorum. Am J Kidney Dis. 2001;37(5):E38.PubMedGoogle Scholar
  146. 146.
    Basker M, Agarwal I, Bendon KS. Congenital nephrotic syndrome-a treatable cause. Ann Trop Paediatr. 2007;27:87–90.PubMedGoogle Scholar
  147. 147.
    Tudorache E, Hogan J, Dourthe ME, Quinet B, Grimprel E, Sellier-Leclerc AL, Ulinski T. Congenital nephrotic syndrome with acute renal failure: questions. Pediatr Nephrol. 2012;47:49–50.Google Scholar
  148. 148.
    Handoko ML, Duijvestein M, Scheepstra CG, de Fijter CW. Syphilis: a reversible cause of nephrotic syndrome. BMJ Case Rep. 2013;pii: bcr2012008279. doi: 10.1136/bcr-2012-008279.Google Scholar
  149. 149.
    Hunte W, Ghraoui F, Cohen RJ. Secondary syphilis and nephrotic syndrome. J Am Soc Nephrol. 1993;3:1351–5.PubMedGoogle Scholar
  150. 150.
    Soehardy Z, Hayati SN, Rozita M, et al. Subclinical acquired syphilis masquerading as membranous glomerulonephritis. Med J Malaysia. 2006;61:484–6.PubMedGoogle Scholar
  151. 151.
    O’Regan S, Fong JS, de Chadarévian JP, Rishikof JR, Drummond KN. Treponemal antigens in congenital and acquired syphilitic nephritis: demonstration by immunofluorescence studies. Ann Intern Med. 1976;85:325–7.PubMedGoogle Scholar
  152. 152.
    Beaufils M, Morel-Maroger L, Sraer JD, Kanfer A, Kourilsky O, Richet G. Acute renal failure of glomerular origin during visceral abscesses. New Engl J Med. 1976;295:185–9.PubMedGoogle Scholar
  153. 153.
    Adra AL, Vigue MG, Dalla Vale F, Ichay L, Raynaud P, Mariani A, Morin D. Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis. Pediatr Nephrol. 2010;25:1765–9.PubMedGoogle Scholar
  154. 154.
    Siomou E, Kollios KD, Papadimitriou P, Kostoula A, Papadopoulou ZL. Acute nephritis and respiratory tract infection caused by Mycoplasma pneumoniae: case report and review of the literature. Pediatr Infect Dis J. 2003;22:1103–6.PubMedGoogle Scholar
  155. 155.
    Carceller Lechón F, de la Torre Espí M, Porto Abal R, Écija Peiró JL. Acute glomerulonephritis associated with pneumonia: a review of three cases. Pediatr Nephrol. 2010;25:161–4.PubMedGoogle Scholar
  156. 156.
    Phillips J, Palmer A, Baliga R. Glomerulonephritis associated with acute pneumococcal pneumonia: a case report. Pediatr Nephrol. 2005;20:1494–5.PubMedGoogle Scholar
  157. 157.
    Krysan DJ, Flynn JT. Renal transplantation after Streptococcus pneumoniae- associated hemolytic uremic syndrome. Am J Kidney Dis. 2001;37:E15.PubMedGoogle Scholar
  158. 158.
    Whitworth JA, Morel-Maroger L, Mignon F, Richet G. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron. 1976;16:1–19.PubMedGoogle Scholar
  159. 159.
    D’Agati VD, Jennette JC, Silva FG. Non-neoplastic kidney diseases. Atlas of nontumor pathology, First series; Fascicle 4. Washington, DC: American Registry of Pathology; 2005. p. 269–96.Google Scholar
  160. 160.
    Black JA, Chaacombe DN, Ockenden BG. Nephrotic syndrome associated with bacteraemia after shunt operations for hydrocephalus. Lancet. 1965;2:921–4.PubMedGoogle Scholar
  161. 161.
    Ho CI, Wen YK, Chen M. Glomerulonephritis with acute renal failure related to osteomyelitis. J Chin Med Assoc. 2008;71:315–7.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Bernardo Rodríguez-Iturbe
    • 2
  • Behzad Najafian
    • 1
  • Alfonso Silva
    • 2
  • Charles E. Alpers
    • 1
  1. 1.Department of PathologyUniversity of WashingtonSeattleUSA
  2. 2.Nephrology ServiceHospital UniversitarioMaracaiboVenezuela

Personalised recommendations